Welcome to our dedicated page for Leveljump Health news (Ticker: JMPHF), a resource for investors and traders seeking the latest updates and insights on Leveljump Health stock.
LevelJump Healthcare Corp. provides teleradiology and diagnostic imaging services through telehealth solutions for client hospitals and imaging centers and in-person radiology services through its Diagnostic Centres. The company’s updates commonly cover operations serving urgent and emergency care settings, financial reporting matters, and public-company capital actions.
Recurring news themes for JMPHF include non-brokered private placements, common-share issuances, stock option grants under its equity incentive plan, shareholder meeting activity, board composition, cooperation agreements, and other governance matters tied to its status as a publicly traded healthcare services company.
LevelJump Healthcare Corp. (TSXV: JUMP) reported its 2023 financial results, highlighting a 36% year-over-year revenue increase to $12.6 million for its Canadian Teleradiology Services (CTS) subsidiary. The company's Q4 2023 revenues were $3.9 million, with a net loss of $(216,708). For the full year 2023, LevelJump reported a net loss of $(2,208,117), while CTS achieved a net profit of $1 million.
Key highlights include:
- Acquisition of 4 Independent Healthcare Facilities in Calgary, Alberta
- Q4 2023 EBITDA of $290,920 and Adjusted EBITDA of $340,920
- Full-year 2023 EBITDA of $(221,329) and Adjusted EBITDA of $78,671
LevelJump's management expects continued growth in 2024, focusing on completing its new Yonge Sheppard Center clinic and integrating the Alberta acquisition.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.